Sources

10 Total Sources

NICE Backs AbbVie’s Elahere for 270 UK Ovarian Cancer Patients as Appraisal Rules Shift

NICE Recommends AbbVie's Elahere for Ovarian Cancer, Widening UK Access

The Guardian6h ago

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England | Ovarian cancer | The Guardian

Mirvetuximab Soravtansine, Ovarian Cancer Drug, Now Available on NHS England

Evening Standard6h ago

Significant breakthrough' as new ovarian cancer treatment approved for NHS use | The Standard

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer | New England Journal of Medicine

bbc.co.uk5h ago

New ovarian cancer drug gives women more time and better quality of life - BBC News

Hundreds of women to benefit from breakthrough ovarian cancer treatment in UK - AOL

Fresh hope for ovarian cancer patients as new treatment given go-ahead | LBC

Yahoo News Canada5h ago

Breakthrough ovarian cancer drug offers patients more time and better quality of life - Yahoo News Canada

Everyday Health5h ago

FR-Alpha-Positive Ovarian Cancer: New Treatments and Breakthroughs